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Selenium has been implicated in immunological function and
many other biological processes through various nutritional
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and biochemical studies (1, 2). This trace element is a natural
component of several prokaryotic and eukaryotic proteins. Although selenium occurs in prokaryotic proteins either as a
cofactor or as a selenocysteine residue, mammalian selenoproteins identified thus far contain selenium only in the form of
selenocysteine, which is the 21st naturally occurring amino
acid in protein. A selenocysteine tRNA that decodes UGA has
been found in all life kingdoms, suggesting that the use of UGA
as a codon for selenocysteine is widespread in nature (2). The
special conserved stem-loop structures in the 39-untranslated
regions of mammalian selenoprotein mRNAs are essential for
recognition of UGA as a codon for selenocysteine, rather than a
codon for termination of translation (3).
Of the eleven genes encoding different selenocysteine-containing proteins that have been found thus far in mammals,
four encode various glutathione peroxidases (reviewed in Refs.
4 and 5), three encode different thyroid hormone deiodinases
(6 – 8), and others encode thioredoxin reductase (9), selenophosphate synthetase 2 (SPS2) (10), selenoprotein P (11), and selenoprotein W (12).
Selenocysteine is located at the active center and is directly
involved, or at least implicated, in the catalytic reactions catalyzed by glutathione peroxidases, thyroid hormone deiodinases, and selenophosphate synthetase 2. Thioredoxin reductase contains selenocysteine (13) in a novel C-terminal GlyCys-Sec-Gly redox motif (14). This center has been implicated
in the peroxidase reaction catalyzed by the enzyme (14) and in
a redox interaction with the N-terminal redox disulfide (15),
although further studies are necessary to prove the suggested
essential role of selenocysteine in this protein. Selenoprotein P,
a protein of unknown function, is unusual in that it contains
ten selenocysteine residues. The function of a selenoprotein W
also remains unknown.
In the present study, the isolation of the 15-kDa protein and
its gene sequence are described which characterize this protein
as a member of a class of mammalian selenoproteins. Although
this new human selenoprotein does not have homology to
known proteins, genes putatively encoding this protein occur in
other mammals as well as in nematodes and plants. Preliminary data on this protein have been presented elsewhere (16).
EXPERIMENTAL PROCEDURES

Materials—[75Se]Selenious acid was obtained from the Research Reactor Facility, University of Missouri (Columbia, MO), ECL systems
were from Amersham Pharmacia Biotech, EST clones were from ATCC
(number 384717 from human placental cDNA library and number
409024 from human infant brain cDNA library), and other reagents
were commercial products of the highest grade available.
Cell Growth and Protein Purification—A human Jurkat T-cell line,
JPX9 (17), was grown and labeled with [75Se]selenious acid (2 mCi/ml)
as described (14). 75Se-Labeled JPX9 cells were mixed with unlabeled
cells, suspended in 2 volumes of 30 mM Tris-HCl, pH 7.5, 1 mM EDTA,
2 mM dithiothreitol, 1 mM MgCl2, 1 mM phenylmethylsulfonyl fluoride,
and disrupted by sonication. Disrupted cells were centrifuged; the su-
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Selenium which occurs in proteins as the amino acid,
selenocysteine, is essential for numerous biological
processes and for human health. A prominent 75Selabeled protein detected in human T-cells migrated as a
15-kDa band by SDS-polyacrylamide gel electrophoresis. This protein subunit was purified and subjected to
tryptic digestion and peptide sequence analyses. Sequences of tryptic peptides derived from the protein
corresponded to a human placental gene sequence containing an open reading frame of 162 residues and a
readthrough in-frame TGA codon. Three different peptide sequences of the 15-kDa protein corresponded to a
nucleotide sequence located downstream of this codon,
suggesting that the T-cell 15-kDa selenoprotein contains
a selenocysteine residue encoded by TGA. Post-translational processing of the N-terminal portion of the predicted gene product to give the 15-kDa protein was suggested on the basis of molecular mass, amino acid
analysis, and immunoblot assays of the purified protein.
The 3*-untranslated region (UTR) of the gene encoding
the 15-kDa protein contained a sequence that is very
similar to the canonical selenocysteine-inserting sequence element. Computer analysis of transcript map
data bases indicated that this gene was located on human chromosome 1. Its coding sequence showed no homology to known protein-encoding genes. The 15-kDa
protein gene was expressed as mRNA in a wide range of
tissues, with increased levels in the thyroid, parathyroid, and prostate-derived cells as evidenced by
searches of partial cDNA sequences in public data bases.
Genes corresponding to the 15-kDa selenocysteinecontaining protein were found in mice and rats, while
the corresponding genes in Caenorhabditis elegans and
Brugia malayi contained a cysteine codon in place of
TGA. The discovery of a new human selenoprotein provides an additional example of the role of selenium in
mammalian systems.

Characterization of a New Human Selenoprotein

RESULTS AND DISCUSSION

Detection, Purification, and Characterization of the 15-kDa
Human Selenoprotein—A human T-cell line, JPX9, was grown
in the presence of 75Se, and the extracts of 75Se-labeled cells
were analyzed by SDS-PAGE and PhosphorImager detection of
radioactivity on the gels. One of the major 75Se-labeled proteins
that migrated as a 15-kDa band on SDS-PAGE was purified
initially on DEAE-Sepharose and phenyl-Sepharose columns
and then further on a reversed-phase column as described
under “Experimental Procedures.” The resulting protein prep1
The abbreviations used are: PAGE, polyacrylamide gel electrophoresis; Sec, selenocysteine; ORF, open reading frame; EST, expressed
sequence tag; dbEST, data base of expressed sequence tags; MALDI,
matrix-assisted laser desorption ionization; 39-UTR, 39-untranslated
region; SECIS element, selenocysteine insertion sequence element;
GPX, glutathione peroxidase.

FIG. 1. Characterization of 75Se-labeled human T-cell 15-kDa
selenoprotein. 75Se-labeled 15-kDa selenoprotein was purified as described under “Experimental Procedures” and analyzed by SDS-PAGE,
PhosphorImager detection, and immunoblot assays. Lane 1, standards
(from top to bottom: 98, 64, 50, 36, 30, 16, and 6 kDa); lane 2, SDS-PAGE
analysis of purified 15-kDa protein; lane 3, PhosphorImager detection
of 75Se in purified 15-kDa protein on SDS gel; lane 4, immunoblot
detection of purified 15-kDa protein; lane 5, immunoblot detection of
15-kDa protein after DEAE purification step. Four individual images,
which were generated by scanning the Coomassie Blue stained gel
(lanes 1 and 2), scanning the PhosphorImager data (lane 3), and scanning the data on films from immunoblots (lanes 4 and 5) were used to
assemble this figure. Location of the 15-kDa protein is indicated by the
arrow.

aration was analyzed by SDS-PAGE. A major protein band
migrating as a 15-kDa species was detected by staining the gels
with Coomassie Blue and by PhosphorImager detection of radioactivity in the gel (Fig. 1). The purity of the 15-kDa protein
was estimated to be about 50%. The native 15-kDa selenoprotein migrated as a 240-kDa species on a native gradient PAGE
and was eluted as a 200-kDa species from a calibrated gelfiltration column (not shown). It was not determined whether
the native 200 –240 kDa protein is composed of multiple identical 15-kDa Se-containing subunits or is a hetero-oligomeric
complex. The molecular mass of the 15-kDa selenoprotein subunit in fractions from the C18 column determined by MALDI
mass-spectrometry was 14,830 Da. Electrospray mass-spectrometry of the same preparation revealed a molecular mass of
14,870 Da. The N terminus of the protein was blocked, which
prevented determination of the N-terminal sequence. Amino
acid analysis revealed the lack of internal methionine and
histidine residues, as well as the hydrophobic character of the
protein (Table I).
Sequences of Tryptic Peptides—The sequences of three different tryptic peptides and one overlapping peptide from the
15-kDa protein were determined (Fig. 2). Computer searches of
the partial cDNAs in the dbEST using TBLASTN program
revealed nucleotide sequences that corresponded to all three
peptides in the same ORF.
Characterization of cDNA and Polypeptide Sequences—Several human dbEST sequences corresponded perfectly to peptides from the 15-kDa protein and were used to assemble an
open reading frame (Fig. 2). The two cDNA clones containing
the longest 59 sequences were obtained from IMAGE and sequenced. These clones revealed a continuous nucleotide sequence of 1268 nucleotides, containing a single open reading
frame of 162 amino acid residues and a 39-end poly(A) tail. A
single ATG codon occurred in a nucleotide context, GCGATGG,
that is similar to the Kozak consensus sequence for initiation of
translation (24). This initiation ATG codon was followed by a
489-nucleotide open reading frame with an in-frame TAA termination codon. The obtained ORF included an in-frame TGA
codon, suggesting the presence of a selenocysteine residue,
Sec-93 (2). Three tryptic peptides for which sequences have
been determined corresponded to deduced sequences located
downstream of the TGA codon, indicating readthrough of the
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pernatant was applied to a DEAE-Sepharose column, which had been
equilibrated with 30 mM Tris-HCl, pH 7.5, 2 mM dithiothreitol, and 1
mM EDTA (buffer A); the column was washed with 2 volumes of buffer
A; and proteins were eluted by application of a linear gradient from 0 to
500 mM NaCl in buffer A. Fractions containing 75Se were analyzed on
SDS gels. Fractions containing the 15-kDa selenoprotein that eluted
from the DEAE column with 350 mM NaCl were combined, concentrated, adjusted to a concentration of 0.5 M ammonium sulfate in buffer
A, and applied to a phenyl-Sepharose column equilibrated in 1 M ammonium sulfate in buffer A; the column was washed by application of a
linear gradient from 0.5 to 0 M ammonium sulfate in buffer A; and
radioactive fractions corresponding to the 15-kDa protein were eluted
by application of a linear gradient from buffer A to water. Radioactive
fractions were combined, concentrated, and loaded on a C18 reversedphase high performance liquid chromatography column that had been
equilibrated in 0.05% trifluoroacetic acid, a gradient of 0 to 60% acetonitrile in 0.05% trifluoroacetic acid applied and 75Se-containing fractions corresponding to the 15-kDa protein eluted at 48% acetonitrile.
Characterization of the 15-kDa Selenoprotein—Fractions containing
the 15-kDa selenoprotein from the C18 column were dried on a SpeedVac SC110 (Savant), dissolved in SDS-PAGE1 sample buffer, and analyzed by SDS-PAGE. The molecular mass of the 15-kDa selenoprotein
was determined by electrospray and MALDI mass-spectrometry in fractions from the C18 column. Both mass spectra revealed a single strong
signal of the 15-kDa protein. The native molecular mass of the 15-kDa
selenoprotein purified on a DEAE-Sepharose column was determined
using native PAGE and analytical high performance liquid chromatography gel filtration as described (18). The 15-kDa selenoprotein was
detected as 75Se-labeled fractions from a gel-filtration column and as a
75
Se-labeled band on native PAGE. For determination of sequences of
internal peptides, the 15-kDa selenoprotein was separated by SDSPAGE, transferred onto a polyvinylidene difluoride membrane, and
stained with Ponceau S. The stained single 15-kDa band was removed
and submitted to Harvard Microchem (Boston, MA), where the 15-kDa
selenoprotein was digested with trypsin and the resulting peptides
were separated on a reversed phase high performance liquid chromatography column and analyzed by MALDI mass-spectrometry and
amino acid sequencing. Amino acid composition of the 15-kDa protein
was also determined at Harvard Microchem. These data were carefully
analyzed and found to be consistent with other experimental data (mass
spectrometry, SDS-PAGE analyses, immunoblot assays).
Immunoblot Detection—Rabbit antibodies were raised against a synthetic polypeptide corresponding to residues 145–162 of the human
15-kDa protein and used for Western blot analyses with ECL systems.
cDNA Sequencing—Plasmids were isolated according to the instructions provided with the plasmid purification kit (Qiagen), the sequencing reaction products were purified on separation columns as described
by the manufacturer (Princeton Separations), and the nucleotide sequences of EST clones were determined using a Dye Terminator Cycle
Sequencing kit as described by the manufacturer (Perkin-Elmer).
Computer Analyses—Three different peptide sequences from the 15kDa selenoprotein were analyzed for matches to the data base of expressed sequence tags (dbEST) of partial cDNA sequences (19) using
the BLAST (20, 21) and gapped BLAST-2 (22) programs. Multiple
alignments of expressed sequence tag (EST) sequences and their translated products were viewed using the MSPcrunch/Blixem system (23).
The Blixem alignments also revealed polymorphic sites in the human
ESTs that were clearly distinct from sequencing errors.
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TGA codon rather than termination of translation. Although
selenocysteine was not directly identified as a component of the
15-kDa protein, the labeling of the protein with 75Se,
readthrough of the TGA codon, and the location of selenocysteine insertion sequence (SECIS) element in the untranslated
area (Fig. 2) suggest the presence of selenocysteine in the
protein. The predicted ORF encoded a protein of 17,790.6 Da.
The mass of the purified 15-kDa protein was 14,870 Da, and
this discrepancy suggested post-translational processing of the
protein. Processing of the 15-kDa protein appears to occur at
the N-terminal portion of the protein. That is, antiserum was
raised to a synthetic peptide that was identical in sequence to

Amino acid

162 Residues

135 Residues

Experimental data

A
R
N
D
C
E
Q
G
H
I
L
K
M
F
P
S
T
W
Y
V
U
E1Q
D1N

13
8
5
8
8
13
8
13
0
5
26
9
1
10
6
13
3
1
2
9
1
21
13

8
7
5
8
7
13
7
10
0
5
20
9
0
9
4
11
2
1
2
6
1
20
13

9.1
6.5
ND
ND
ND
ND
ND
12.9
,0.5
5.0
19.2
9.3
,0.5
7.5
5.0
11.4
3.2
ND
2.7
6.7
ND
21.4
14.6

FIG. 2. Human cDNA sequence encoding a 15-kDa Se-containing protein. In the deduced amino acid sequence, the putative signal peptide
is shown in lowercase, and the most probable site of post-translational cleavage is indicated by an upward arrow. The amino acid U represents
selenocysteine 93 encoded by an in-frame TGA codon (overlined). The sequences of four tryptic peptides, for which amino acid sequences were
experimentally determined, are underlined. Mass spectrometry data for these peptides are consistent with the amino acid sequences. In the
39-UTR, the positions of the selenocysteine insertion sequence (SECIS element, see text and Fig. 4) and the poly(A) addition signal (dotted
underline) are shown.
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TABLE I
Amino acid composition of the human 15-kDa selenoprotein
The 162 residue sequence corresponds to a full size open reading
frame. The 135 residue sequence corresponds to the open reading frame
after removal of 27 N-terminal residues. Experimental data were obtained as described under “Experimental Procedures” and were normalized to a 14.87-kDa molecular mass for the purified protein determined
by mass-spectrometry. U represents selenocysteine.

the eighteen C-terminal residues of the 15-kDa protein, and
thus the antigenic site resides near the C terminus. As shown
in Fig. 1, this antiserum recognized 15-kDa protein at different
stages of purification. In addition, one of the sequenced tryptic
peptides obtained from digests of the 15-kDa protein corresponded to residues 146 –158, which are located near the C
terminus according to the predicted gene sequence.
The N-terminal portion of the putative precursor of the 15kDa protein, as predicted from the gene sequence, had a stretch
of hydrophobic amino acid residues, suggesting the presence of
a signal peptide. Cleavage of these N-terminal amino acid
residues is consistent with the amino acid composition of the
protein (Table I) since the processed protein matches more
closely the amino acid analysis data obtained for the purified
15-kDa protein than the full size 17-kDa protein. One possible
site for post-translational processing is Ser-27, which coincides
with the site of an exon-intron junction (not shown), making
this residue the evolutionary favorable site for post-translational processing. The unknown nature of the N-terminal modifying group in the purified protein makes it difficult to predict
the exact site of post-translational cleavage.
Homologous Mouse, Rat, Brugia malayi, Caenorhabditis elegans, and Rice Gene Sequences—Computer sequence analyses
of the 15-kDa protein and its gene sequence revealed no homology to known proteins. However, a number of dbEST sequences
from mouse, rat, B. malayi, C. elegans, and rice showed strong
homology in TBLASTN searches with the 15-kDa human protein (Fig. 3). Mouse partial cDNA sequences were assembled
into a full-length open reading frame, whereas rat, C. elegans,
B. malayi, and rice sequences gave only partial coding sequences. Interestingly, although mouse and rat genes encode
potential selenocysteine-containing 15-kDa proteins, the genes
in C. elegans and B. malayi encode homologous proteins containing cysteine in place of selenocysteine. This is consistent
with observations that nematode genes for glutathione peroxidase and thioredoxin reductase encode cysteine analogs of
mammalian selenocysteine-containing proteins.
The regions flanking Sec-93 in the human 15-kDa protein
had the highest degree of homology among proteins from different organisms, suggesting that the selenocysteine residue is
located in a putative active center. In other mammalian sel-
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enocysteine-containing proteins in which the function is established, the selenocysteine residue is located at the active center, and it is essential for catalytic activity of the selenoenzyme
(1, 2).
In addition to partial cDNA sequences summarized in Fig. 3,
we have detected additional homologous human and mouse
cDNAs relatively distantly related to the sequence for the human 15-kDa protein. These encode hypothetical proteins that
have in-frame TGA in the position corresponding to the TGA
encoding selenocysteine in the 15-kDa selenoprotein gene. The
sequences of human and mouse genes for this protein were
recently experimentally verified.2 These observations suggest
that the 15-kDa selenoprotein establishes a new class of eukaryotic selenium-containing proteins.
Gene Expression—Approximately 120 partial cDNA sequences in dbEST were found to match the human 15-kDa
protein DNA sequence (within experimental error or expected
frequencies of natural polymorphism). This sampling represents a sufficient abundance of independent clones to reveal
the approximate tissue distribution of expression of this relatively highly expressed gene (expression as mRNA). cDNA
libraries from 32 different adult, fetal, or embryonic tissues or
organs were represented in this set of sequences. Table II
shows the ranked incidence of these clones in tissues and
organs for which at least one library has two or more independent 15-kDa protein cDNAs in dbEST.
Clearly, the 15-kDa protein gene exhibits a very broad spectrum of moderate expression in many tissues, and significantly
higher levels of mRNA are shown by thyroid, parathyroid tumor, prostate, and pre-cancerous prostate cells. Expression
estimates from dbEST library frequencies should be considered
to be only semi-quantitative, considering that some libraries
are normalized and variable levels of tissue contamination may
exist. More quantitative representative estimates are given by
the stringent CGAP (Cancer Gene Anatomy Project) libraries
(25) prepared from small numbers of laser-microdissected cells,
for example the pre-cancerous prostate library CGAP_Pr2 (Ref.
26; Table II). Irrespective of the quantitative uncertainties, this
2

V. Gladyshev and D. Hatfield, unpublished data.

TABLE II
Incidence of the human 15-kDa protein gene expression
Incidence of the human 15-kDa protein gene expression is based on
the occurrence of two or more independent cDNA clones in dbEST
libraries. In addition, 17 libraries from other tissues, including 3 distinct embryo libraries, contained only a single 15-kDa protein cDNA
clone and are not tabulated here. For some clones, both 59 and 39 EST
sequences are present in dbEST; these count as only a single cDNA in
these calculations.
Library

Incidence per 10,000 ESTs
(numbers/library size)

Thyroid
Parathyroid tumor (Soares NbHPA)
Prostate pre-cancerous cells (CGAP_Pr2)
Prostate
Fetal lung (Soares NbHL19W)
Colon carcinoma (3 libraries)
Aorta
Fetal retina (Stratagene 937202)
Jurkat T-cells (2 libraries)
Retina (2 libraries)
Neuroepithelium (Stratagene 937231)
Colon (Stratagene 937204)
Testis (Soares NHT)
Fetal heart (Soares NbHH19W)
Germinal B-cells (CGAP_GCB1)

19.9 (4/2014)
18.4 (12/6511)
15.4 (3/1945)
11.2 (2/1792)
9.8 (9/9145)
5.6 (2/3358, 1/2791, 1/956)
4.4 (2/4595)
4.3 (2/4610)
4.3 (2/3534, 1/3420)
4.1 (3/8915, 2/3368)
3.7 (2/5385)
3.3 (3/8974)
2.9 (4/13657)
2.3 (6/25708)
1.0 (2/19194)

large body of partial cDNA sequence data strongly demonstrates that the 15-kDa protein gene is expressed in a wide
range of tissues, with increased levels of mRNA in the thyroid,
parathyroid, and prostate-derived cells. Although in this report
we describe the human 15-kDa protein gene expression as the
expression of mRNA inferred from data base analysis, we detected the mouse analog of this human selenoprotein in immunoblot assays in prostate, heart, kidney, spleen, liver, and other
mouse organs, with the highest level observed in prostate,
suggesting the expression of both mRNA and the selenoprotein
in many tissues and cell lines.2
Selenocysteine Insertion Sequence Element—Studies of the
mechanism of selenocysteine incorporation into several eukaryotic selenoproteins have implicated related stem-loop
structures, located in the mRNA 39-UTR, as essential for selenocysteine insertion into proteins at a UGA codon in the
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FIG. 3. Alignment of the human 15-kDa selenoprotein sequence with homologs from mouse, nematodes, and rice. The amino acid
sequence of the mouse protein was deduced from the assembly of 39 independent partial cDNA sequences in dbEST. In addition, experimental
confirmation of the 59 region encoding the mouse N-terminal sequence was made from partial cDNAs obtained from the IMAGE consortium. The
C. elegans sequence was assembled from two partial cDNA clones (GenBankTM dbEST accession numbers C10051 and C08344) that are identical
for an 81-base-pair region of overlap and encode the apparently complete reading frame shown. The partial amino acid sequence of the homolog
from the filarial nematode, B. malayi, was translated from a single partial cDNA (GenBankTM dbEST accession number AA257328). Two rice
partial cDNAs (GenBankTM dbEST accession numbers D47693, D47819) covered the translated region shown (in addition, shorter segments of
similarity to the human sequence were noted in translations further downstream, but these were in error-prone regions of mismatch between the
two ESTs and are not shown). All pairwise alignments were strongly significant, as shown by TBLASTX-2 (Washington University gapped blast,
February 1997 release obtained from ftp://blast.wustl.edu/blast/executables). Typical EST pairs gave amino acid gapped E (expect) values
(BLOSUM 62 matrix), using the sum statistics of Altschul and Gish (22) as follows (with the highest HSP score appended in parentheses):
human/mouse, 2 3 10235 (717); human/C. elegans, 2 3 10220 (252); human/B. malayi, 8 3 10212 (228); C. elegans/B. malayi, 8 3 10221 (257);
human/rice (including multiple short matches for scoring purposes), 1 3 1022 (82).
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coding sequence. The general structural features of this SECIS
(selenocysteine insertion sequence) element have been deduced
previously (3, 27), based on chemical probe experiments and
sequence alignments, as summarized in Fig. 4a.
To locate potential SECIS elements in the 15-kDa protein
mRNAs, the human and mouse cDNAs were searched for sequences meeting the following constraints (see Fig. 4a): Helix I,
at least 4 base pairs; Internal loop, 3–9 nucleotides; Quartet
(the non-Watson-Crick base-paired motif), UGAN (following A
in Internal loop) . . . NGAN (following the downstream strand
of Helix II); Helix II, 9 –15 standard base pairs extending the
Quartet; Apical loop, 10 –20 nucleotides starting with AA(A/G).
Single base mismatches or bulges were allowed within helices
longer than 6 base pairs.
Sequences meeting these stringent criteria were found in
both the human and mouse 39-UTRs, ending approximately 60
nucleotides upstream of the poly(A) addition signal sequence
(Fig. 2). Fig. 4b shows these human and mouse sequences
aligned with the canonical SECIS element (3, 27) of the human
glutathione peroxidase 1 (GPX-1) mRNA 39-UTR. The 15-kDa
protein mRNAs exhibit all the features known to be necessary
in other eukaryotic selenoprotein mRNAs to promote seleno-

cysteine insertion. It was also noted from the alignments of
multiple human sequences from dbEST that a probable G/A
substitution polymorphism occurred at an Apical loop nucleotide (position 1125, Fig. 4b). Examination of the primary
sequencer trace data (openly available on the Washington
University server, http://genome.wustl.edu/est/est_general/trace_intro.html) confirmed that authentic G or A bases occur at
this position and are not sequencing errors. An additional site
of substitution (C/T) polymorphism was observed at the 811
position of the human 15-kDa protein cDNA sequence
(not shown).
Chromosomal Localization of the Gene for the 15-kDa Selenoprotein—Computer analyses revealed the UNIGENE cluster of
ESTs (28), corresponding to the 15-kDa human selenoprotein,
maps to human chromosome 1, at the position 117–123 cM on
the human transcript gene map, corresponding approximately
to 1p31 (29).
Concluding Remarks—We have detected a new selenoprotein in human T cells designated as the 15-kDa protein. Although the function of this protein is not known, certain selenoproteins have been associated with a chemopreventive role
in cancer (2). Interestingly, there are certain correlations be-

Downloaded from www.jbc.org at UNIV OF NEBRASKA - Lincoln on October 10, 2007

FIG. 4. SECIS elements. a, general features of eukaryotic SECIS elements used to identify a matching element in the 39-UTRs of the mRNAs
encoding human and mouse 15-kDa selenoproteins (see text). The helical segment of four non-Watson-Crick base pairs is labeled Quartet. b,
alignment of the predicted SECIS elements of the human and mouse mRNAs encoding the 15-kDa protein with a typical experimentally verified
example (human GPX-1). In helical stems, single base bulges or mismatches are shown by gaps in the arrows. A lowercase a residue above the
human apical loop sequence indicates a polymorphism at position 1125.

Characterization of a New Human Selenoprotein
tween the occurrence of the newly described 15-kDa protein in
cancer tissue and the effect of selenium on cancer that are
worthy of discussion. For example, recent studies have shown
that supplementation of the diet with selenium in human clinical trials resulted in 63% reduction in prostate cancer and, to
a lesser extent, in the reduction of colon and lung cancers (30).
Interestingly, the 15-kDa protein is highly expressed in prostate tissue (see Table II) and thus some of the protective properties of selenium in prostate cancer may be mediated through
this protein. In addition, our preliminary data suggest that the
levels of the 15-kDa protein and its mRNA are decreased in
some cancers (e.g. liver of c-myc/TGFa transgenic mice2). Studies to determine whether the 15-kDa protein may play a role in
delaying the progression of certain cancers including prostate
cancer are in progress.
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